Original Article|Articles in Press

An Assessment of the Practice of Neuromuscular Blockade and the Association Between Its Prophylactic Use and Outcomes Among Postoperative Pediatric Cardiac Patients

Published:February 22, 2023DOI:


      The authors investigated the management of neuromuscular blocking agents (NMBAs) for pediatric patients after cardiac surgery, and compared the outcomes of patients who received prophylactic NMBA (pNMBA) infusions and patients without pNMBA infusions.


      A retrospective cohort study.


      At a tertiary teaching hospital.


      Patients younger than 18, with congenital heart disease, who underwent cardiac surgery.


      Commencement of NMBA infusion in the first 2 hours after surgery

      Measurements and Main Results

      The primary endpoint was a composite of one or more of the following major adverse events (MAEs) that occurred within 7 days after surgery: death from any cause, a circulatory collapse that needed cardiopulmonary resuscitation, and requirement for extracorporeal membrane oxygenation. The secondary endpoints included the total duration of mechanical ventilation for the first 30 days after surgery. A total of 566 patients were included in this study. The MAEs occurred in 13 patients (2.3%). An NMBA was commenced within 2 hours after surgery in 207 patients (36.6%). There were significant differences in the incidence of postoperative MAEs between the pNMBA group and the non-pNMBA group (5.3% v 0.6%; p < 0.001). In multivariate regression models, pNMBA infusion was not significantly associated with the incidence of MAEs (odds ratio: 1.79, 95% CI: 0.23-13.93, p = 0.58), but was significantly associated with prolonged mechanical ventilation by 3.85 days (p < 0.001).


      Postoperative prophylactic neuromuscular blockade after cardiac surgery can be associated with prolonged mechanical ventilation, but has no association with MAEs among pediatric patients with congenital heart disease.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fisher DM.
        Neuromuscular blocking agents in paediatric anaesthesia.
        Br J Anaesth. 1999; 83: 58-64
        • Slutsky AS.
        Neuromuscular blocking agents in ARDS.
        N Engl J Med. 2010; 363: 1176-1180
        • Crean P.
        Sedation and neuromuscular blockade in paediatric intensive care; practice in the United Kingdom and North America.
        Paediatr Anaesth. 2004; 14: 439-442
        • Vernon DD
        • Witte MK.
        Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children.
        Crit Care Med. 2000; 28: 1569-1571
        • Bernier ML
        • Romer LH
        • Bembea MM.
        Spectrum of current management of pediatric pulmonary hypertensive crisis.
        Crit Care Explor. 2019; 1: e0037
        • Ishi K
        • Koga Y
        • Onitsuka T
        • et al.
        [Postoperative respiratory care in congenital heart disease with pulmonary hypertension–continuous muscle relaxation therapy].
        Kyobu Geka. 1986; 39 (880-9)
        • Abman SH
        • Hansmann G
        • Archer SL
        • et al.
        Pediatric pulmonary hypertension: Guidelines from the American Heart Association and American Thoracic Society.
        Circulation. 2015; 132: 2037-2099
        • Hermans G
        • Van den Berghe G.
        Clinical review: Intensive care unit acquired weakness.
        Crit Care. 2015; 19: 274
        • Vender JS
        • Szokol JW
        • Murphy GS
        • et al.
        Sedation, analgesia, and neuromuscular blockade in sepsis: An evidence-based review.
        Crit Care Med. 2004; 32: S554-S561
        • De Jonghe B
        • Bastuji-Garin S
        • Durand MC
        • et al.
        Respiratory weakness is associated with limb weakness and delayed weaning in critical illness.
        Crit Care Med. 2007; 35: 2007-2015
        • Garnacho-Montero J
        • Madrazo-Osuna J
        • Garcia-Garmendia JL
        • et al.
        Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients.
        Intensive Care Med. 2001; 27: 1288-1296
        • Hunter JM.
        Reversal of residual neuromuscular block: Complications associated with perioperative management of muscle relaxation.
        Br J Anaesth. 2017; 119: i53-i62
        • Patel AK
        • Trujillo-Rivera E
        • Faruqe F
        • et al.
        Sedation, analgesia, and neuromuscular blockade: An assessment of practices from 2009 to 2016 in a national sample of 66,443 pediatric patients cared for in the ICU.
        Pediatr Crit Care Med. 2020; 21: e599-e609
        • Gaies MG
        • Gurney JG
        • Yen AH
        • et al.
        Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.
        Pediatr Crit Care Med. 2010; 11: 234-238
        • O'Brien SM
        • Clarke DR
        • Jacobs JP
        • et al.
        An empirically based tool for analyzing mortality associated with congenital heart surgery.
        J Thorac Cardiovasc Surg. 2009; 138: 1139-1153
        • Bando K
        • Turrentine MW
        • Sharp TG
        • et al.
        Pulmonary hypertension after operations for congenital heart disease: Analysis of risk factors and management.
        J Thorac Cardiovasc Surg. 1996; 112 (1600-7; discussion 1607-9)
        • Atherton DP
        • Hunter JM.
        Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
        Clin Pharmacokinet. 1999; 36: 169-189
        • Jenkins IA
        • Playfor SD
        • Bevan C
        • et al.
        Current United Kingdom sedation practice in pediatric intensive care.
        Paediatr Anaesth. 2007; 17: 675-683
        • Baumgartner H
        • De Backer J
        • Babu-Narayan SV
        • et al.
        2020 ESC Guidelines for the management of adult congenital heart disease.
        Eur Heart J. 2021; 42: 563-645
        • Karsenty C
        • Khraiche D
        • Jais JP
        • et al.
        Predictors of low exercise cardiac output in patients with severe pulmonic regurgitation.
        Heart. 2021; 107: 223-228
        • Song B
        • Dang H
        • Dong R.
        Analysis of risk factors of low cardiac output syndrome after congenital heart disease operation: What can we do.
        J Cardiothorac Surg. 2021; 16: 135
        • Medicus L
        • Thompson L.
        Preventing pulmonary hypertensive crisis in the pediatric patient after cardiac surgery.
        Am J Crit Care. 1995; 4 (quiz 54-45): 49-53
        • Valverde Montoro D
        • Garcia Soler P
        • Hernandez Yuste A
        • et al.
        Ultrasound assessment of ventilator-induced diaphragmatic dysfunction in mechanically ventilated pediatric patients.
        Paediatr Respir Rev. 2021; 40: 58-64
        • Guess R
        • Vaewpanich J
        • Coss-Bu JA
        • et al.
        Risk factors for ventilator-associated events in a PICU.
        Pediatr Crit Care Med. 2018; 19: e7-e13
        • Cocoros NM
        • Priebe G
        • Gray JE
        • et al.
        Factors associated with pediatric ventilator-associated conditions in six U.S. hospitals: A nested case-control study.
        Pediatr Crit Care Med. 2017; 18: e536-e545
        • Da Silva PS
        • Neto HM
        • de Aguiar VE
        • et al.
        Impact of sustained neuromuscular blockade on outcome of mechanically ventilated children.
        Pediatrics Int. 2010; 52: 438-443
        • Groetzinger LM
        • Hutchins AT
        • Rivosecchi RM.
        An evaluation of continuous infusion rocuronium for sustained neuromuscular blockade in critically ill adults.
        Ann Pharmacother. 2021; 55: 732-737
        • Playfor S
        • Jenkins I
        • Boyles C
        • et al.
        Consensus guidelines for sustained neuromuscular blockade in critically ill children.
        Paediatr Anaesth. 2007; 17: 881-887
        • Corso L.
        Train-of-four results and observed muscle movement in children during continuous neuromuscular blockade.
        Crit Care Nurse. 2008; 28 (30-8; quiz 39)
        • Lemson J
        • Driessen JJ
        • van der Hoeven JG.
        The effect of neuromuscular blockade on oxygen consumption in sedated and mechanically ventilated pediatric patients after cardiac surgery.
        Intensive Care Med. 2008; 34: 2268-2272